Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
10.61
USD
Gesponsert
-0.03
-0.28%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
10.61
0.00
0.00%
OACC Ergebnisberichte
Positives Überraschungsverhältnis
Keine Daten verfügbar für OACC
%
Nächster Bericht
Datum des nächsten Berichts
10. März 2026
Estimate forQ4 25(Revenue/ EPS)
--
/
--
Implizierte Änderung vonQ3 25(Revenue/ EPS)
--
/
--
Implizierte Änderung vonQ4 24(Revenue/ EPS)
--
/
--
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share earnings per share and revenue
On 13. Nov. 2025, OACC reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share expected to report next?
The next earning report is scheduled for 10. März 2026.
What are the forecasts for Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's next earnings report?
Based on --
analysts, Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share is expected to report EPS of -- and revenue of -- for Q4 2025.